Table 2.

Results from exploratory tests of different cutoffs for early step increase as predictors of change in accelerometer-measured steps and MVPA at end-of-treatment and follow-up, controlling for study length.

Accelerometer-measured steps as outcome
			End-of-treatment		Follow-up
Week 1–3 average step change cutoff	N above	N below	b	P	b	p
0	37	15	1667.42	0.040	700.55	0.436
500	29	23	1830.90	0.010	1583.88	0.046
750	25	27	1937.23	0.007	1503.01	0.063
1000	22	30	1929.05	0.007	1488.29	0.066
1500	12	40	957.62	0.245	1480.30	0.101
2000	7	45	2389.53	0.020	3043.92	0.008
Accelerometer-measured MVPA as outcome
			End-of-treatment		Follow-up
Week 1–3 average step change cutoff	N above	N below	b	P	b	p
0	37	15	6.88	0.284	3.59	0.582
500	29	23	11.16	0.051	9.98	0.086
750	25	27	11.30	0.052	7.73	0.192
1000	22	30	13.68	0.017	10.00	0.093
1500	12	40	12.69	0.052	12.42	0.060
2000	7	45	26.65	0.001	22.60	0.007

MVPA = moderate-to-vigorous physical activity.